Status:
COMPLETED
Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO)
Lead Sponsor:
Mansoura University
Conditions:
Small Bowel Obstruction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Mini abstract : Altogether 100 patients with 117 episodes of ASBO were randomized into control and gastrografin groups. Eight episodes in eight patients were excluded. Gastrografin group showed a sig...
Detailed Description
Abstract Background: Many published studies have shown that Gastrografin can be used for diagnosis post operative acute small bowel obstruction (ASBO) and assessing the need for surgical interventio...
Eligibility Criteria
Inclusion
- Patients admitted to our surgical department by postoperative SBO were considered for inclusion in this trial.
Exclusion
- Age less than 18 years
- Large bowel obstruction
- Recent (within 4 weeks) abdominal surgery
- Ileus
- Cancer peritonitis
- Peritonitis
- Strangulation symptoms and signs
- Obstructed abdominal wall or groin hernia
- Subtotal or total colectomy
- All patients in whom the final diagnosis was not SBO
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00738855
Start Date
February 1 2006
End Date
January 1 2008
Last Update
November 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospital
Al Mansurah, Egypt